Silvant Capital Management’s Tenet Healthcare THC Stock Holding History

Silvant Capital Management’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,028	Closed	-$2.44M	–	317
2025 Q3	$2.44M	Sell	12,028 -1,137	-9%	-$202K	0.08%	118
2025 Q2	$2.32M	Buy	13,165 +4,652	+55%	+$700K	0.09%	121
2025 Q1	$1.14M	Sell	8,513 -40,257	-83%	-$5.3M	0.05%	145
2024 Q4	$6.16M	Hold	48,770	–	–	0.26%	57
2024 Q3	$8.11M	Sell	48,770 -14,173	-23%	-$2.14M	0.36%	37
2024 Q2	$8.37M	Hold	62,943	–	–	0.37%	38
2024 Q1	$6.62M	Hold	62,943	–	–	0.32%	47
2023 Q4	$4.76M	Hold	62,943	–	–	0.26%	61
2023 Q3	$4.15M	Hold	62,943	–	–	0.25%	62
2023 Q2	$5.12M	Sell	62,943 -19,971	-24%	-$1.42M	0.29%	59
2023 Q1	$4.93M	Hold	82,914	–	–	0.32%	60
2022 Q4	$4.05M	Sell	82,914 -860	-1%	-$39.7K	0.29%	68
2022 Q3	$4.32M	Buy	+83,774	New	+$4.97M	0.29%	62

Other funds holding THC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Silvant Capital Management's THC Position: Q4 2025 in Review

Silvant Capital Management sold out of Tenet Healthcare (THC) in Q4 2025, closing a stake of 12,028 shares — an estimated $2.44M sold.

Silvant Capital Management first reported a position in THC in Q3 2022 and held it in 13 quarters. The position peaked at $8.37M in Q2 2024. 705 funds tracked by Wall St. Rank hold THC as of Q4 2025.

Silvant Capital Management reported no remaining Tenet Healthcare position as of Q4 2025 after selling out during the quarter.
Silvant Capital Management sold 12,028 Tenet Healthcare shares in Q4 2025, an estimated $2.44M.
Silvant Capital Management first reported a position in Tenet Healthcare in Q3 2022 and held it in 13 quarters.
Silvant Capital Management's Tenet Healthcare position peaked at $8.37M in Q2 2024.
705 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2025.

Based on Silvant Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.